Efficacy and safety of eslicarbazepine acetate as add-on treatment in patients with focal-onset seizures: Integrated analysis of pooled data from double-blind phase III clinical studies

Pharmacokinetics and drug interactions of eslicarbazepine acetate

(2012) Meir Bialer et al.   EPILEPSIA

Pharmacokinetics of eslicarbazepine acetate at steady-state in adults with partial-onset seizures

(2011) E. Perucca et al.   EPILEPSY RESEARCH

Effect of renal impairment on the pharmacokinetics of eslicarbazepine acetate

(2011) J. Maia et al.   INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS

Eslicarbazepine acetate as adjunctive therapy in adult patients with partial epilepsy

(2010) E. Ben-Menachem et al.   EPILEPSY RESEARCH

Efficacy and safety of 800 and 1200 mg eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures

(2009) A. Gil-Nagel et al.   ACTA NEUROLOGICA SCANDINAVICA

Pharmacokinetic interaction study between eslicarbazepine acetate and lamotrigine in healthy subjects

(2009) L. Almeida et al.   ACTA NEUROLOGICA SCANDINAVICA

Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: A randomized, double-blind, placebo-controlled, parallel-group phase III study

(2009) Christian Elger et al.   EPILEPSIA

Pharmacokinetics, Efficacy, and Tolerability of Eslicarbazepine Acetate in Children and Adolescents With Epilepsy

(2008) Luis Almeida et al.   JOURNAL OF CLINICAL PHARMACOLOGY